Mitochondrial InjuryLessons from the Fialuridine Trial

被引：0
|
作者：
Pieter Honkoop
Hans R. Scholte
Robert A. de Man
Solko W. Schalm
机构：
[1] Erasmus University Hospital,Department of Internal Medicine II (Section Hepatology)
[2] Erasmus University Hospital,Department of Biochemistry
[3] Erasmus University Hospital,Department of Internal Medicine II (Ca 326)
来源：
Drug Safety | 1997年 / 17卷
关键词：
Chronic Hepatitis; Lamivudine; Zidovudine; Lactic Acidosis; Nucleoside Analogue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Fialuridine is an antiviral agent with potent activity against hepatitis B virus replication in vitro and in vivo. In a phase II study, 7 of 15 patients experienced severe toxicity due to the drug after 9 to 13 weeks of treatment. Adverse effects included nausea, vomiting and painful paraesthesia; subsequently, hepatic failure, pancreatitis, neuropathy, myopathy and lactic acidosis developed, probably due to multisystem mitochondrial toxicity.
引用
收藏
页码：1 / 7
页数：6
相关论文
共 50 条
  • [31] Mitochondrial follies: From mitochondrial science to comics to health promotion
    Azul, A. Marisa
    Tavares, R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 18 - 18
  • [32] A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
    Berk, Michael
    Turner, Alyna
    Malhi, Gin S.
    Ng, Chee
    Cotton, Susan M.
    Dodd, Seetal
    Samuni, Yuval
    Tanious, Michelle
    McAulay, Claire
    Dowling, Nathan
    Sarris, Jerome
    Owen, Lauren
    Waterdrinker, Astrid
    Smith, Deidre
    Dean, Olivia M.
    BMC MEDICINE, 2019, 17 (1)
  • [33] A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
    Michael Berk
    Alyna Turner
    Gin S. Malhi
    Chee H. Ng
    Susan M. Cotton
    Seetal Dodd
    Yuval Samuni
    Michelle Tanious
    Claire McAulay
    Nathan Dowling
    Jerome Sarris
    Lauren Owen
    Astrid Waterdrinker
    Deidre Smith
    Olivia M. Dean
    BMC Medicine, 17
  • [34] From mitochondrial dynamics to arrhythmias
    Aon, M. A.
    Cortassa, S.
    Akar, F. G.
    Brown, D. A.
    Zhou, L.
    O'Rourke, B.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (10): : 1940 - 1948
  • [35] MITOCHONDRIAL DNA FROM PROTOZOA
    SUYAMA, Y
    PREER, JR
    GENETICS, 1965, 52 (05) : 1051 - &
  • [36] MITOCHONDRIAL PREPARATIONS FROM FLOWERS
    HULME, AC
    WOOLTORTON, LSC
    JONES, JD
    NATURE, 1964, 201 (492) : 795 - &
  • [37] Trial and Error: How the Unclonable Human Mitochondrial Genome was Cloned in Yeast
    Bigger, Brian W.
    Liao, Ai-Yin
    Sergijenko, Ana
    Coutelle, Charles
    PHARMACEUTICAL RESEARCH, 2011, 28 (11) : 2863 - 2870
  • [38] Trial and Error: How the Unclonable Human Mitochondrial Genome was Cloned in Yeast
    Brian W. Bigger
    Ai-Yin Liao
    Ana Sergijenko
    Charles Coutelle
    Pharmaceutical Research, 2011, 28 : 2863 - 2870
  • [39] PHASE 3 TRIAL OF COENZYME Q10 IN MITOCHONDRIAL DISEASES
    Staepoole, P. W.
    Kurtz, T. L.
    Kerr, D. S.
    Feigenbaum, A.
    DeGrauw, T.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 93 - 94
  • [40] Phase 3 trial of coenzyme Q10 in mitochondrial diseases
    Kurtz, Tracie L.
    MITOCHONDRION, 2010, 10 (02) : 231 - 231
12345